Screener
Veradermics MANE Business Segments — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Veradermics’s 10-K, filed March 30, 2026.
- Filed
- Mar 30, 2026, 5:35 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001827635-26-000013
| (in thousands, except share and per share amounts) | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Other income (expenses): | ||
| Interest income | 1,562 | 481 |
| Other income | 790 | 394 |
| Interest expense | — | (585) |
| Total other income, net | 2,352 | 290 |
| Loss before income taxes | (69,995) | (26,488) |
| Income tax benefit | — | — |
| Net loss | $(69,995) | $(26,488) |
Item 16. Form 10-K Summary
FAQ
- What is Veradermics's business segments — interest expense?
- Veradermics (MANE) reported business segments — interest expense of $0 in Q4 2025.
- How has Veradermics's business segments — interest expense changed year-over-year?
- Veradermics's business segments — interest expense decreased by 100.0% year-over-year, from $146.25K to $0.
- What does business segments — interest expense mean?
- This metric measures the total cost of debt financing incurred by a specific business segment during the reporting period. It captures the interest paid on loans, credit facilities, or other debt instruments allocated to the segment's operations. Monitoring this helps investors understand the segment's reliance on external leverage and the impact of financing costs on its operating margins.
Ask your AI about Veradermics's business segments — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude